Given that our previous study with HSPB5 demonstrated attenuated LN in the MRL/lpr lupus mouse model [25], we were interested in comparing the efficacy of HSPB5 to a glucocorticoid. This evidence concerns the gene CRYAB and lobular neoplasia.